Parkinson's disease (PD) is a devastating diagnosis with, however, potential for an extremely intriguing aesthetic component. Despite motor and cognitive deficits, an emerging collection of studies report a burst of visual artistic output and alterations in produced art in a subgroup of patients. This provides a unique window into the neurophysiological bases for why and how we might create and enjoy visual art, as well as into general brain function and the nature of PD or other neurodegenerative diseases. However, there has not been a comprehensive organization of literature on this topic. Nor has there been an attempt to connect case evidence and knowledge on PD with present understanding of visual art making in psychology and neuroaesthetics in order to propose hypotheses for documented artistic changes. Here, we collect the current research on this topic, tie this to PD symptoms and neurobiology, and provide new theories focusing on dopaminergic neuron damage, over-stimulation from dopamine agonist therapy, and context or genetic factors revealing the neurobiological basis of the visual artistic brain.Parkinson's disease (PD) is a neurodegenerative disease affecting roughly 0.3% of the population, rising rapidly to 3% over the age of sixty-five (Gillies et al., 2014). PD progressively impacts brain cells' ability to produce the neurotransmitter dopamine, and leading, along with spreading brain lesions, to a number of symptoms from issues with motor control and cognitive processes (including language and memory), as well as sensory, and emotional regulation (Chaudhuri et al., 2006;Sveinbjornsdottir, 2016). These symptoms can only be slowed but not presently cured by a combination of medications or invasive procedures, thus, in conjunction with an aging world population, making PD an increasingly pressing target for research.At the same time, and in addition to its obvious medical importance, emerging evidence also suggests something quite surprising that can accompany the disease onset: As reported in a number of case studies, with diagnosis and antiparkinsonian treatment, a subset of individuals appear to experience a sudden awakening of artistic creativity and desire, and/or changes in the style or even in the quality of their produced art. A survey by Joutsa et al. (2012a) has in fact suggested such changes in up to 20% of respondents. This can be found with famous artists, for example Salvador Dali (Forsythe et al., 2017), and is documented on the website of the Parkinson's Disease Foundation, which until recently kept a database of visual artworks in addition to other